UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): June 16, 2014

                                 AMERICANN, INC.
                     ---------------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                     000-54231                27-4336843
   -------------------------        ----------------          ---------------
 (State or other jurisdiction     (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 114
                                Denver, CO 80216
                ------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000


                             1550 Larimer, Ste. 264
                                Denver, CO 80202
             -----------------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[]  Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

<PAGE>


Item 1.01.  Entry Into a Material Definitive Agreement

     On June 16, 2014, the Company entered into an option  agreement to purchase
a five-acre parcel of undeveloped land in Denver, Colorado. The Company plans to
develop the property as a facility  called the "Denver  Cannabis  Center." Plans
for the Denver Cannabis Center include the construction of a 126,000 square foot
facility that would include greenhouse and indoor cultivation areas that will be
sold to licensed cannabis operators. The Company does not cultivate,  process or
sell cannabis.

     Additional  plans  for  the  Denver  Cannabis  Center  include  a  cannabis
dispensary,   a  research  facility,  a  training  center,  an  infused  product
production facility and corporate offices.

     The Company  paid the seller  $250,000  for the option which amount will be
applied toward the purchase price of $2,250,000 at the closing. The closing must
take place on or before July 31,  2014.  If the  Company  fails to close by that
date,  through no fault of the seller,  the Company  will  forfeit the  $250,000
deposit.

     The Company  plans to develop  comparable  facilities  in other states that
allow for the production and sale of cannabis.  The Company's ability to develop
the Denver Cannabis Center, as well as its plans for other states, is contingent
upon its  ability to obtain  the  capital  required  to fund the  projects.  The
Company  estimates that the cost to build and develop the Denver Cannabis Center
will be approximately $8.5 million.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: July 8, 2014
                                      AMERICANN, INC.


                                      By:/s/ Timothy Keogh
                                         -----------------------------------
                                         Timothy Keogh, Chief Executive
                                         Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101optagree7-14.txt", "description": "8-K ITEM 1.01", "secsgml_size_bytes": 4222}]
{"company-data": {"conformed-name": "Americann, Inc.", "cik": "0001508348", "assigned-sic": "6770", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "14964880"}, "business-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(303) 839-0061"}, "mail-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): June 16, 2014

                                 AMERICANN, INC.
                     ---------------------------------------
             (Exact name of registrant as specified in its charter)

          Delaware                     000-54231                27-4336843
   -------------------------        ----------------          ---------------
 (State or other jurisdiction     (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 114
                                Denver, CO 80216
                ------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

                             1550 Larimer, Ste. 264
                                Denver, CO 80202
             -----------------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[]  Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
    Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry Into a Material Definitive Agreement

     On June 16, 2014, the Company entered into an option  agreement to purchase
a five-acre parcel of undeveloped land in Denver, Colorado. The Company plans to
develop the property as a facility  called the "Denver  Cannabis  Center." Plans
for the Denver Cannabis Center include the construction of a 126,000 square foot
facility that would include greenhouse and indoor cultivation areas that will be
sold to licensed cannabis operators. The Company does not cultivate,  process or
sell cannabis.

     Additional  plans  for  the  Denver  Cannabis  Center  include  a  cannabis
dispensary,   a  research  facility,  a  training  center,  an  infused  product
production facility and corporate offices.

     The Company  paid the seller  $250,000  for the option which amount will be
applied toward the purchase price of $2,250,000 at the closing. The closing must
take place on or before July 31,  2014.  If the  Company  fails to close by that
date,  through no fault of the seller,  the Company  will  forfeit the  $250,000
deposit.

     The Company  plans to develop  comparable  facilities  in other states that
allow for the production and sale of cannabis.  The Company's ability to develop
the Denver Cannabis Center, as well as its plans for other states, is contingent
upon its  ability to obtain  the  capital  required  to fund the  projects.  The
Company  estimates that the cost to build and develop the Denver Cannabis Center
will be approximately $8.5 million.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: July 8, 2014
                                      AMERICANN, INC.

                                      By:/s/ Timothy Keogh
                                         -----------------------------------
                                         Timothy Keogh, Chief Executive
                                         Officer